ZA898611B - Hydrates of beta-lactam antibiotic - Google Patents

Hydrates of beta-lactam antibiotic

Info

Publication number
ZA898611B
ZA898611B ZA898611A ZA898611A ZA898611B ZA 898611 B ZA898611 B ZA 898611B ZA 898611 A ZA898611 A ZA 898611A ZA 898611 A ZA898611 A ZA 898611A ZA 898611 B ZA898611 B ZA 898611B
Authority
ZA
South Africa
Prior art keywords
hydrates
beta
lactam antibiotic
lactam
antibiotic
Prior art date
Application number
ZA898611A
Other languages
English (en)
Inventor
Thomas Michael Eckrich
Michael Eckrich Thomas
Carol Elaine Pasini
Elaine Pasini Carol
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA898611B publication Critical patent/ZA898611B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA898611A 1988-11-14 1989-11-10 Hydrates of beta-lactam antibiotic ZA898611B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27179488A 1988-11-14 1988-11-14

Publications (1)

Publication Number Publication Date
ZA898611B true ZA898611B (en) 1991-07-31

Family

ID=23037114

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA898611A ZA898611B (en) 1988-11-14 1989-11-10 Hydrates of beta-lactam antibiotic

Country Status (13)

Country Link
EP (1) EP0369686A1 (ru)
JP (1) JPH02178281A (ru)
KR (1) KR900007840A (ru)
CN (1) CN1042712A (ru)
AU (1) AU620659B2 (ru)
CA (1) CA2002596A1 (ru)
DK (1) DK563789A (ru)
HU (1) HU205113B (ru)
IL (1) IL92271A0 (ru)
NZ (1) NZ231368A (ru)
PT (1) PT92275A (ru)
SU (1) SU1757468A3 (ru)
ZA (1) ZA898611B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002597C (en) * 1988-11-14 1999-03-23 Thomas M. Eckrich Solvates of b-lactam antibiotic
CA2034592C (en) * 1990-01-26 2001-06-05 Ralph R. Pfeiffer Crystalline hydrochloride of new beta-lactam antibiotic and process therefor
US5352782A (en) * 1993-06-04 1994-10-04 Eli Lilly And Company Process for preparing crystalline β-lactam monohydrate
US5374719A (en) * 1993-06-04 1994-12-20 Eli Lilly And Company Process for converting loracarbef dihydrate to loracarbef monohydrate
US5399686A (en) * 1993-06-04 1995-03-21 Eli Lilly And Company Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5412094A (en) * 1993-06-28 1995-05-02 Eli Lilly And Company Bicyclic beta-lactam/paraben complexes
US5580977A (en) * 1995-03-01 1996-12-03 Eli Lilly And Company Process for preparing loracarbef monohydrate
US6001996A (en) * 1995-05-11 1999-12-14 Eli Lilly And Company Complexes of cephalosporins and carbacephalosporins with parabens
ZA978515B (en) * 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
WO2004046142A1 (en) * 2002-11-21 2004-06-03 Ranbaxy Laboratories Limited Monohydrate solvates of loracarbef
ATE406364T1 (de) 2003-03-07 2008-09-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
ES2318274T3 (es) 2003-03-07 2009-05-01 Schering Corporation Compuestos de azetidinona sustituida, formulaciones y uso de los mismos para el tratamiento de hipercolesterolemia.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155548C (no) * 1979-02-10 1987-04-15 Kyowa Hakko Kogyo Kk Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger.
DD273634A5 (de) * 1987-10-06 1989-11-22 ����@�����@�����@����k�� Verfahren zur herstellung eines kristallinen monohydrats eines 1-carbacephalosporins
ZA89829B (en) * 1988-02-05 1990-10-31 Lilly Co Eli Crystalline b-lactam solvate
CA2002597C (en) * 1988-11-14 1999-03-23 Thomas M. Eckrich Solvates of b-lactam antibiotic

Also Published As

Publication number Publication date
AU620659B2 (en) 1992-02-20
HU205113B (en) 1992-03-30
JPH02178281A (ja) 1990-07-11
PT92275A (pt) 1990-05-31
KR900007840A (ko) 1990-06-02
SU1757468A3 (ru) 1992-08-23
AU4457089A (en) 1990-05-31
DK563789D0 (da) 1989-11-10
CN1042712A (zh) 1990-06-06
IL92271A0 (en) 1990-07-26
NZ231368A (en) 1990-12-21
DK563789A (da) 1990-05-15
EP0369686A1 (en) 1990-05-23
HUT52508A (en) 1990-07-28
CA2002596A1 (en) 1990-05-14

Similar Documents

Publication Publication Date Title
ZA862575B (en) Antibiotic clathrates
HU893412D0 (en) Inhibitors of interleucin-1
ZA898611B (en) Hydrates of beta-lactam antibiotic
ZA893483B (en) Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics
ZA872593B (en) Beta-lactam antibiotics
AU2725988A (en) Derivatives of lincosaminide antibiotics
DE3479731D1 (en) Substituted phenylglycine derivatives of beta-lactam antibiotics
AU5147185A (en) Beta-lactam antibiotics
IL89150A0 (en) Crystalline beta-lactam solvate
IE893642L (en) Hydrates of beta-lactam antibiotic
GB8518124D0 (en) Cephalosporin antibiotics
AU2337188A (en) Monohydrate and solvates of a new beta-lactam antibiotic
GB8627404D0 (en) Cephalosporin antibiotics
ZA889365B (en) Hydrates of andinotropic agent
GB8629677D0 (en) Cephalosporin antibiotics
GB8526901D0 (en) Cephalosporin antibiotics
GB8526900D0 (en) Cephalosporin antibiotics
ZA86395B (en) Novel beta-lactam antibiotics
GB8522137D0 (en) Cephalosporin antibiotic
IE853252L (en) Beta-lactam antibiotics
JPS6434991A (en) Carbonylation of beta-lactam antibiotic
CS693488A1 (en) Derivatives of sulphonamides
GB8608963D0 (en) Beta-lactam antibiotics
IE890337L (en) Beta-lactam antibiotics
IE851622L (en) Cephalosporin antibiotics